Micot Pharmaceutical sharessurged 64.8% in Hong Kong’s grey market trading.

Micot Pharmaceutical is a Chinese biotechnology company specializing in the discovery, development and commercialization of bi-/multi-specific peptide drugs for metabolic diseases, as well as cardiovascular and cerebrovascular diseases. Micot Pharma plans to list H shares on the Hong Kong Stock Exchange Main Board on June 24, 2026.

Its Core Product, MT1013, is a self-developed Phase III-stage dual-targeting receptor agonist polypeptide mainly designed to treat chronic kidney disease-secondary hyperparathyroidism.

Seer Tech shares jumped 9.5% in Hong Kong’s grey market trading.

Seer Tech is a Chinese intelligent robotics company specializing in proprietary robotic control systems, robot controllers, software, robots and related accessories. Seer Tech plans to list on the Hong Kong Stock Exchange on June 24, 2026.

Seer’s robotic control systems serve as the “robot brain,” supporting perception, positioning, decision-making, motion control, scheduling and optimization across robot fleets. The company develops and sells robots, controllers, software and accessories for use in industrial automation and other real-world applications. It has a customer base of more than 2,000 integrators and end customers across over 35 countries and regions, with products deployed in more than 20 sectors including 3C, automotive, new energy, semiconductors, construction machinery and biopharmaceuticals.